Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.3 was added to the study record history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check11 days agoChange DetectedThe study record title was updated to use the uHCC abbreviation and corrected wording, and the recruitment status was changed to Active, not recruiting; additional sections such as Contacts/Locations, Eligibility, Outcome Measures, and Arms and Interventions were added.SummaryDifference2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe Record History page now includes links to 'Check who can join' and 'Find Contact Information' and shows the revision label updated to v3.6.0 from v3.5.5.SummaryDifference0.5%

- Check32 days agoChange DetectedThe page now shows the latest site revision as v3.5.5, replacing v3.5.4. This indicates a platform update that does not change the trial data.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision label in the Record History updated from v3.5.3 to v3.5.4, indicating a small update to the site’s versioning metadata. The change does not modify the study data or primary content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page footer has been updated to reflect a new ClinicalTrials.gov site revision number (from v3.5.2 to v3.5.3). This represents a platform/version update without changing the study record content shown on the page.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.